Hip Replacement Devices Market to Grow with a CAGR of 3.05% through 2030

Rising Prevalence of Osteoarthritis and Degenerative Hip Disorders and Expanding Geriatric Population Globally are expected to drive the Global Hip Replacement Devices Market growth in the forecast period, 2026-2030

According to TechSci Research report, “Hip Replacement Devices Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Hip Replacement Devices Market stood at USD 5.78 Billion in 2024 and is anticipated to grow with a CAGR of 3.05% in the forecast period.

Breakthroughs in implant materials, surgical instrumentation, and minimally invasive procedures are fundamentally transforming the landscape of hip replacement. Next-generation biomaterials such as highly cross-linked polyethylene, porous titanium, and advanced ceramics deliver superior biocompatibility, reduced wear, and longer implant lifespan, which directly translates into better patient outcomes and lower revision rates. Modern implant designs now offer improved anatomical conformity, facilitating faster post-operative recovery and enhanced joint function. The integration of robotic-assisted systems, intraoperative navigation, and computer-guided tools is elevating surgical precision, minimizing procedural variability, and significantly reducing the risk of complications. These innovations are enhancing the overall clinical value proposition of hip replacement procedures building surgeon confidence, improving patient satisfaction, and supporting higher procedural adoption. From a commercial perspective, they enable manufacturers to achieve product differentiation in a highly competitive market, particularly in premium device segments where performance and outcomes are critical.

Developing regions are rapidly scaling their capabilities in orthopedic surgery, resulting in significant growth potential for the hip replacement market. Countries across Asia-Pacific, Latin America, and the Middle East are heavily investing in hospital infrastructure, surgeon training, and orthopedic specialty programs. Government-backed healthcare reforms and the expansion of medical tourism hubs are making joint replacement surgeries more accessible and cost-effective for a broader patient base. Increased urbanization, lifestyle-related joint degeneration, and better public health awareness prompting earlier diagnosis and elective surgical intervention. These shifts are catalyzing market expansion into regions historically considered underserved. As procedural volumes increase and surgical capabilities mature, global device manufacturers are gaining access to new revenue streams, reducing dependency on the saturated markets of North America and Europe.

Incentivized by supportive health policies and payer frameworks, hip replacement surgery is becoming more financially viable for patients worldwide. In the United States, total hip arthroplasty is fully reimbursed under Medicare and most private insurance plans, eliminating a key cost barrier for older adults. Across Europe, positive health technology assessments (HTAs) reinforce the cost-effectiveness of hip replacement, which strengthens policy support for procedural growth. The adoption of bundled payments and value-based care models is prompting hospitals to prioritize devices that offer efficiency, durability, and improved patient outcomes. Favorable reimbursement environments reduce the economic friction associated with surgery, encouraging both patient uptake and provider participation. For manufacturers, this creates an attractive commercial setting to scale both standard and advanced hip implant solutions, further accelerating market penetration and brand preference.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Hip Replacement Devices Market”

The Global Hip Replacement Devices Market is segmented into product type, end user, regional distribution, and company.

Based on its end user, the Hospitals segment has emerged as the predominant market leader. Hospitals are equipped with the full spectrum of surgical infrastructure, including advanced operating rooms, specialized orthopedic departments, and post-operative recovery units. This makes them the preferred setting for total hip arthroplasty (THA), revision surgeries, and complex cases that require multidisciplinary support. High-volume hospitals often serve as centers of excellence for joint replacement, handling a significantly larger share of cases than outpatient facilities or smaller clinics. These institutions are also more likely to adopt robotic-assisted systems, navigation technologies, and next-generation implants, further reinforcing their position in the value chain.

In many developed countries, reimbursement structures and bundled payment models are designed around hospital-based procedures. For example, in the United States, Medicare and commercial insurers primarily reimburse hip replacement surgeries when performed in inpatient or hospital-affiliated outpatient settings. Hospitals also tend to have dedicated billing departments and established insurance relationships, streamlining the financial process for both patients and payers. In cases of hip fractures or failed implants, hospitals are the default destination due to their capacity to provide 24/7 emergency services and manage complex revision surgeries. The rising need for revision hip replacements, especially among aging patients with prior implants, adds to hospitals' procedural volume.

Based on region, The Asia Pacific region is poised to experience the fastest growth in the Global Hip Replacement Devices Market, Countries such as China, Japan, India, South Korea, and Australia are experiencing a sharp rise in their elderly populations, which directly correlates with higher incidence rates of osteoarthritis, osteoporosis, and hip fractures. For example, by 2030, Asia will be home to over 60% of the world’s elderly, many of whom will require joint replacement interventions as mobility declines.

APAC nations are making substantial investments in orthopedic care infrastructure, including the establishment of specialty hospitals, joint replacement centers, and surgeon training programs. Public and private hospital groups are upgrading facilities with advanced surgical platforms, such as navigation-assisted systems and robotic technologies, enabling the region to perform more complex and high-volume procedures. Several governments are expanding health insurance coverage and subsidized surgery programs, making elective procedures like hip replacements more financially accessible. In India, schemes like Ayushman Bharat are covering joint replacements for lower-income patients. In China, hip implants have been included in the centralized procurement system, reducing prices and encouraging broader adoption.

Major companies operating in Global Hip Replacement Devices Market are:

• Johnson & Johnson (DePuy Synthes)
• B. Braun Melsungen AG
• Stryker Corporation
• Zimmer Biomet Holdings Inc
• Corin Group
• Waldemar LINK GmbH & Co. KG
• MicroPort Scientific Corporation
• Exactech, Inc.
• Conformis Inc.
• OMNIlife Science Inc

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The Global Hip Replacement Devices Market is poised for sustained expansion, driven by a combination of demographic aging, rising prevalence of degenerative joint disorders, and continuous advancements in implant technology and surgical techniques. As healthcare systems worldwide prioritize mobility restoration and quality of life, demand for hip arthroplasty procedures is expected to remain strong across both developed and emerging economies. Market growth will be further propelled by favorable reimbursement frameworks, increased procedural accessibility, and rising investments in orthopedic infrastructure, particularly in high-growth regions like Asia Pacific. For device manufacturers, this evolving landscape presents significant opportunities for product innovation, strategic partnerships, and global market penetration, cementing hip replacement as a critical pillar of modern musculoskeletal care.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Hip Replacement Devices Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product Type (Primary Hip Reconstruction Devices, Partial Hip Reconstruction Devices, Revision Hip Reconstruction Devices, Hip Resurfacing Devices), By End User (Hospitals, Ambulatory Care Centers, Orthopedics Clinics, Others), By Region, & Competition, 2020-2030F”, has evaluated the future growth potential of Global Hip Replacement Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Hip Replacement Devices Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]